OncoScint image atlas., PMID:1576344
Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients., PMID:1576345
A practical approach to planar and SPECT imaging of 111In-CYT-103., PMID:1576346
Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma., PMID:1576351
OncoScint CR103 imaging in the surgical management of patients with colorectal cancer., PMID:1576352
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT., PMID:1523304
Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer., PMID:8418688
Challenges in immunoscintigraphy of ovarian cancer., PMID:8462895
Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer., PMID:8462896
Monoclonal antibodies in ovarian and prostate cancer., PMID:8511599
In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma., PMID:8319398
Oncoscint for detection of disseminated colorectal and ovarian cancer., PMID:8497207
In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer., PMID:8508386
Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma., PMID:8403703
111In-CYT-103 immunoscintigraphy in ovarian cancer., PMID:8276314
Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates., PMID:8242578
Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma., PMID:8131088
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management., PMID:8306832
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice., PMID:8018538
Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in ovarian cancer. A pilot study., PMID:8048395
Uptake of In-111 GYK-DTPA B72.3 monoclonal antibody in metastatic squamous cell carcinoma., PMID:7805331
Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer., PMID:7817200
Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application., PMID:7942701
Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT., PMID:7842571
Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity., PMID:7715898
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations., PMID:7750217
Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT., PMID:7724757
Splenic metastasis from colon carcinoma imaged using In-111 OncoScint., PMID:7648747
Diagnostic use of radiolabeled antibodies for cancer., PMID:8924373
False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma., PMID:8565379
Intense uptake of In-111 satumomab pendetide in an inflammatory mass., PMID:8741891
Lipomas as a potential cause for uptake of In-111 MAb72.3 (Oncoscint CR)., PMID:8925626
111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?, PMID:8620800
The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report., PMID:8635097
Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer., PMID:8823804
Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis., PMID:8853918
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy., PMID:8790198
Site of mistletoe injection observed on In-111 OncoScint imaging., PMID:9031776
In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma., PMID:9099487
Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18., PMID:9544680
Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer., PMID:9754756
Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging., PMID:9755434
Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody., PMID:10088160
Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature., PMID:10451876
Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer., PMID:11768830
[Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence]., PMID:12001423
Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma., PMID:12790934
Radioimmunodetection of colorectal carcinoma., PMID:12845972
[Indium 111-labeled antibodies in the detection of colorectal carcinoma]., PMID:15307496
[Immunoscintigraphy of prostatic cancer]., PMID:17058687
Favorable results in cancer imaging and therapy using monoclonal antibodies, PMID: 1837471
Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103, PMID: 1879645
Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT, PMID: 7842571
Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer, PMID: 1576343
Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer, PMID: 1576342
Splenic metastasis from colon carcinoma imaged using In-111 OncoScint, PMID: 7648747
Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer, PMID: 8462896
In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma, PMID: 8319398
Oncoscint for detection of disseminated colorectal and ovarian cancer, PMID: 8497207
Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients, PMID: 1576345
Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer, PMID: 11768830
Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity, PMID: 7715898
Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer, PMID: 8418688
[Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence], PMID: 12001423
111In-CYT-103 immunoscintigraphy in ovarian cancer, PMID: 8276314
Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in ovarian cancer. A pilot study, PMID: 8048395
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT, PMID: 1523304
In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results, PMID: 2315476
Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18, PMID: 9544680
In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma, PMID: 9099487
Radioimmunodetection of colorectal carcinoma, PMID: 12845972
[Indium 111-labeled antibodies in the detection of colorectal carcinoma], PMID: 15307496
Uptake of In-111 GYK-DTPA B72.3 monoclonal antibody in metastatic squamous cell carcinoma, PMID: 7805331
OncoScint image atlas, PMID: 1576344
False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma, PMID: 8565379
Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma, PMID: 12790934
In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer, PMID: 8508386
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice, PMID: 8018538
The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report, PMID: 8635097
Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT, PMID: 7724757
Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody, PMID: 10088160
Site of mistletoe injection observed on In-111 OncoScint imaging, PMID: 9031776
Challenges in immunoscintigraphy of ovarian cancer, PMID: 8462895
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy, PMID: 8790198
OncoScint CR103 imaging in the surgical management of patients with colorectal cancer, PMID: 1576352
A practical approach to planar and SPECT imaging of 111In-CYT-103, PMID: 1576346
[Immunoscintigraphy of prostatic cancer], PMID: 17058687
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations, PMID: 7750217
Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma, PMID: 1576351
Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma, PMID: 8131088
Monoclonal antibodies in ovarian and prostate cancer, PMID: 8511599
Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature, PMID: 10451876
Diagnostic use of radiolabeled antibodies for cancer, PMID: 8924373
Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis, PMID: 8853918
Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer, PMID: 7817200
Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging, PMID: 9755434
Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer, PMID: 8823804
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management, PMID: 8306832
Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates, PMID: 8242578
Intense uptake of In-111 satumomab pendetide in an inflammatory mass, PMID: 8741891
For research use only. Not for human or drug use.
